Navigation Links
CSA Medical Selected to Present at AdvaMed 2010: The MedTech Conference
Date:10/7/2010

BALTIMORE, Oct. 7 /PRNewswire/ -- Following a highly selective application process, CSA Medical, Inc. (www.CSAmedical.com) has been selected to present the company's background, progress and future plans for its proprietary spray cryotherapy platform on Tuesday, October 19, 2010 at AdvaMed 2010. The presentation will take place from 10:20-10:50 am at the Walter E. Washington Convention Center in Washington, D.C.

CSA Medical is first to harness the power of extreme cold, liquid nitrogen (-196 C), therapeutic energy delivery inside the body. This unique technology (device, catheter and agent) allows delivery of therapeutic doses of a cryogen to destroy diseased tissue inside the body while preserving the stromal matrix. This cell death with scaffolding preservation is unique to liquid nitrogen spray cryotherapy. Financial highlights, product development and commercialization plans for CSA Medical's novel Spray Cryotherapy technology will be overviewed during the presentation.

"We are looking forward to a busy and exciting meeting as our schedule is full with strategic partner and investor meetings," said Steve Schaefer, the company's President and CFO. "CSA Medical addresses the expanding need for minimally invasive treatment options.  Patients and physicians want clinically effective therapy with less pain and morbidity and quick recovery when possible.  Patented, spray cryotherapy delivers on these needs as evidenced by the growing number of users and procedures performed."

AdvaMed is the national trade association for medical device, diagnostic and heath information system companies. These companies manufacture 90% of the health care technology produced annually in the United States and 50% globally. The annual MedTech conference will attract over 1,400 business leaders, entrepreneurs, policy-makers, media, financiers, and other industry stakeholders from around the world including 500+ CEOs, Presidents and C-level executives.

CSA Medical, Inc. develops and manufactures a proprietary therapeutic interventional platform, the CryoSpray Ablation™ System.  The CSA System utilizes a patented spray cryogenic technology that allows a physician to freeze and destroy a wide range of unwanted tissues via an endoscope.

For more information, please contact Richard Hughen at rhughen@csamedical.com or www.CSAmedical.com.Contact: Richard HughenCSA Medical, Inc.Phone: (443) 921-8053Fax: (866) 641-5157rhughen@csamedical.com
'/>"/>

SOURCE CSA Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Globus Medical Raises $110 Million in Series E Financing Round
5. Quark Pharmaceuticals Appoints New Chief Medical Officer
6. Boston University Biomedical Engineers Find Chink in Bacterias Armor
7. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
8. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
9. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
10. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
11. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2017)... ROCKVILLE, Md. , July 13, 2017  New York ... watchers of pharmaceutical markets should be aware of.  From new ... These trends are detailed in a recently completed study, ... following: 1.  Age-Driven ... years, we have been aware of the impact the growing ...
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  Bayer has awarded grants totaling more than ... of its prestigious Bayer Hemophilia Awards Program (BHAP). Four U.S. ... Philadelphia and Uniformed Services University of the Health ... winners. Grant recipients were announced last night during a reception ... Congress, Berlin, Germany . ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... July 21, 2017 , ... Fresh Wave® IAQ today announced the ... solution for colleges and universities at the APPA 2017 Annual Conference and ... and tobacco smoke odors without the use of harsh chemicals, Fresh Wave IAQ Smoke ...
(Date:7/21/2017)... , ... July 21, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... use of violence and aggression to solve problems and pleads with world leaders to be ... armed forces do not bring peace. He says there is a peaceful and positive way ...
(Date:7/21/2017)... , ... July 21, 2017 , ... West Dermatology is ... Doan Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large ... of experience in dermatology, skin cancer , and more. She graduated from the ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... ChenMed ... MD, has joined JenCare Senior Medical Center as Richmond Chief Medical Officer. ... School of Medicine, and Associate Chief Medical Officer of Ambulatory Services for the UVA ...
(Date:7/20/2017)... ... July 20, 2017 , ... Remote Medical ... their iMedSecure™ comes included with each system installation. RMT’s iMedHD2™ Telepathology ... participants for real-time collaboration and immediate decision-making requirements. While never sharing IP ...
Breaking Medicine News(10 mins):